Brief: Propanc Biopharma Announces Nasdaq Uplisting And Pricing Of $4 Million Public Offering
Aug 14 (Reuters) - Propanc Biopharma Inc PPCB.PK: PROPANC BIOPHARMA ANNOUNCES NASDAQ UPLISTING AND PRICING OF $4 MILLION PUBLIC OFFERING PROPANC BIOPHARMA INC - PRICES PUBLIC OFFERING OF 1,000,000 SHARES AT $4.00 EACH Source text: ID:nGNX72y6Sg Further company coverage: PPCB.PK ((Reuters.Briefs@thomsonreuters.com;))